Creo Medical Group (LON:CREO) Trading Up 1.4%

Creo Medical Group PLC (LON:CREOGet Free Report)’s stock price rose 1.4% on Friday . The stock traded as high as GBX 36.50 ($0.47) and last traded at GBX 36.50 ($0.47). Approximately 327,983 shares changed hands during trading, a decline of 56% from the average daily volume of 740,865 shares. The stock had previously closed at GBX 36 ($0.46).

Creo Medical Group Trading Up 1.4 %

The stock has a market cap of £131.94 million, a PE ratio of -521.43 and a beta of 0.86. The firm has a 50-day moving average price of GBX 35.61 and a 200-day moving average price of GBX 36.59. The company has a debt-to-equity ratio of 13.88, a quick ratio of 2.19 and a current ratio of 3.83.

About Creo Medical Group

(Get Free Report)

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.

See Also

Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.